These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 27693462)

  • 1. Ghrelin O-acyltransferase (GOAT) enzyme is overexpressed in prostate cancer, and its levels are associated with patient's metabolic status: Potential value as a non-invasive biomarker.
    Hormaechea-Agulla D; Gómez-Gómez E; Ibáñez-Costa A; Carrasco-Valiente J; Rivero-Cortés E; L-López F; Pedraza-Arevalo S; Valero-Rosa J; Sánchez-Sánchez R; Ortega-Salas R; Moreno MM; Gahete MD; López-Miranda J; Requena MJ; Castaño JP; Luque RM
    Cancer Lett; 2016 Dec; 383(1):125-134. PubMed ID: 27693462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma ghrelin O-acyltransferase (GOAT) enzyme levels: A novel non-invasive diagnosis tool for patients with significant prostate cancer.
    Gómez-Gómez E; Jiménez-Vacas JM; Carrasco-Valiente J; Herrero-Aguayo V; Blanca-Pedregosa AM; León-González AJ; Valero-Rosa J; Fernández-Rueda JL; González-Serrano T; López-Miranda J; Gahete MD; Castaño JP; Requena-Tapia MJ; Luque RM
    J Cell Mol Med; 2018 Nov; 22(11):5688-5697. PubMed ID: 30256519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In1-Ghrelin Splicing Variant as a Key Element in the Pathophysiological Association Between Obesity and Prostate Cancer.
    Jiménez-Vacas JM; Montero-Hidalgo AJ; Gómez-Gómez E; Fuentes-Fayos AC; Ruiz-Pino F; Guler I; Camargo A; Anglada FJ; Carrasco-Valiente J; Tena-Sempere M; Sarmento-Cabral A; Castaño JP; Gahete MD; Luque RM
    J Clin Endocrinol Metab; 2021 Nov; 106(12):e4956-e4968. PubMed ID: 34255835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The oncogenic role of the In1-ghrelin splicing variant in prostate cancer aggressiveness.
    Hormaechea-Agulla D; Gahete MD; Jiménez-Vacas JM; Gómez-Gómez E; Ibáñez-Costa A; L-López F; Rivero-Cortés E; Sarmento-Cabral A; Valero-Rosa J; Carrasco-Valiente J; Sánchez-Sánchez R; Ortega-Salas R; Moreno MM; Tsomaia N; Swanson SM; Culler MD; Requena MJ; Castaño JP; Luque RM
    Mol Cancer; 2017 Aug; 16(1):146. PubMed ID: 28851363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ghrelin-O-Acyltransferase (GOAT) Enzyme as a Novel Potential Biomarker in Gastroenteropancreatic Neuroendocrine Tumors.
    Herrera-Martínez AD; Gahete MD; Sánchez-Sánchez R; Alors-Perez E; Pedraza-Arevalo S; Serrano-Blanch R; Martínez-Fuentes AJ; Gálvez-Moreno MA; Castaño JP; Luque RM
    Clin Transl Gastroenterol; 2018 Oct; 9(10):196. PubMed ID: 30297816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ghrelin O-acyltransferase (GOAT) is expressed in prostate cancer tissues and cell lines and expression is differentially regulated in vitro by ghrelin.
    Seim I; Jeffery PL; de Amorim L; Walpole CM; Fung J; Whiteside EJ; Lourie R; Herington AC; Chopin LK
    Reprod Biol Endocrinol; 2013 Jul; 11():70. PubMed ID: 23879975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Utility of Ghrelin-O-Acyltransferase (GOAT) Enzyme as a Diagnostic Tool and Potential Therapeutic Target in Prostate Cancer.
    Jiménez-Vacas JM; Gómez-Gómez E; Montero-Hidalgo AJ; Herrero-Aguayo V; L-López F; Sánchez-Sánchez R; Guler I; Blanca A; Méndez-Vidal MJ; Carrasco J; Lopez-Miranda J; Requena-Tapia MJ; Castaño JP; Gahete MD; Luque RM
    J Clin Med; 2019 Nov; 8(12):. PubMed ID: 31766715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidermal Growth Factor-Containing Fibulin-Like Extracellular Matrix Protein 1 (EFEMP1) Acts as a Potential Diagnostic Biomarker for Prostate Cancer.
    Shen H; Zhang L; Zhou J; Chen Z; Yang G; Liao Y; Zhu M
    Med Sci Monit; 2017 Jan; 23():216-222. PubMed ID: 28085790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Panel of Biomarkers for Diagnosis of Prostate Cancer Using Urine Samples.
    Guo J; Yang J; Zhang X; Feng X; Zhang H; Chen L; Johnson H; Persson JL; Xiao K
    Anticancer Res; 2018 Mar; 38(3):1471-1477. PubMed ID: 29491074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An overview of ghrelin
    Moose JE; Leets KA; Mate NA; Chisholm JD; Hougland JL
    Expert Opin Ther Pat; 2020 Aug; 30(8):581-593. PubMed ID: 32564644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Diagnostic of Prostate Cancer From Body Fluids Using Methylation-Specific PCR (MS-PCR) Method.
    Minciu R; Dumache R; Gheorghe P; Daminescu L; Rogobete AF; Ionescu D
    Clin Lab; 2016; 62(6):1183-6. PubMed ID: 27468582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using gene expression from urine sediment to diagnose prostate cancer: development of a new multiplex mRNA urine test and validation of current biomarkers.
    Mengual L; Lozano JJ; Ingelmo-Torres M; Izquierdo L; Musquera M; Ribal MJ; Alcaraz A
    BMC Cancer; 2016 Feb; 16():76. PubMed ID: 26856686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In1-ghrelin, a splice variant of ghrelin gene, is associated with the evolution and aggressiveness of human neuroendocrine tumors: Evidence from clinical, cellular and molecular parameters.
    Luque RM; Sampedro-Nuñez M; Gahete MD; Ramos-Levi A; Ibáñez-Costa A; Rivero-Cortés E; Serrano-Somavilla A; Adrados M; Culler MD; Castaño JP; Marazuela M
    Oncotarget; 2015 Aug; 6(23):19619-33. PubMed ID: 26124083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Splice variant transcripts of the anterior gradient 2 gene as a marker of prostate cancer.
    Neeb A; Hefele S; Bormann S; Parson W; Adams F; Wolf P; Miernik A; Schoenthaler M; Kroenig M; Wilhelm K; Schultze-Seemann W; Nestel S; Schaefer G; Bu H; Klocker H; Nazarenko I; Cato AC
    Oncotarget; 2014 Sep; 5(18):8681-9. PubMed ID: 25237833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long non-coding RNA metastasis associated in lung adenocarcinoma transcript 1 derived miniRNA as a novel plasma-based biomarker for diagnosing prostate cancer.
    Ren S; Wang F; Shen J; Sun Y; Xu W; Lu J; Wei M; Xu C; Wu C; Zhang Z; Gao X; Liu Z; Hou J; Huang J; Sun Y
    Eur J Cancer; 2013 Sep; 49(13):2949-59. PubMed ID: 23726266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary Nucleic Acid TSPAN13-to-S100A9 Ratio as a Diagnostic Marker in Prostate Cancer.
    Yan C; Kim YH; Kang HW; Seo SP; Jeong P; Lee IS; Kim D; Kim JM; Choi YH; Moon SK; Yun SJ; Kim WJ
    J Korean Med Sci; 2015 Dec; 30(12):1784-92. PubMed ID: 26713053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ghrelin O-acyltransferase (GOAT) and energy metabolism.
    Li Z; Mulholland M; Zhang W
    Sci China Life Sci; 2016 Mar; 59(3):281-91. PubMed ID: 26732975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrated RNA and metabolite profiling of urine liquid biopsies for prostate cancer biomarker discovery.
    Lee B; Mahmud I; Marchica J; Dereziński P; Qi F; Wang F; Joshi P; Valerio F; Rivera I; Patel V; Pavlovich CP; Garrett TJ; Schroth GP; Sun Y; Perera RJ
    Sci Rep; 2020 Feb; 10(1):3716. PubMed ID: 32111915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary Polyamines: A Pilot Study on Their Roles as Prostate Cancer Detection Biomarkers.
    Tsoi TH; Chan CF; Chan WL; Chiu KF; Wong WT; Ng CF; Wong KL
    PLoS One; 2016; 11(9):e0162217. PubMed ID: 27598335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.